Published in Biochem Pharmacol on March 15, 1988
Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J Pharmacol Exp Ther (1973) 5.23
Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J Pharmacol Exp Ther (1973) 4.40
Bromobenzene-induced liver necrosis. Protective role of glutathione and evidence for 3,4-bromobenzene oxide as the hepatotoxic metabolite. Pharmacology (1974) 4.32
Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J Pharmacol Exp Ther (1973) 3.89
Acetaminophen-induced hepatic injury: protective role of glutathione in man and rationale for therapy. Clin Pharmacol Ther (1974) 2.62
Acetaminophen-induced hepatic necrosis. 3. Cytochrome P-450-mediated covalent binding in vitro. J Pharmacol Exp Ther (1973) 1.90
Acetaminophen-induced hepatic necrosis. VI. Metabolic disposition of toxic and nontoxic doses of acetaminophen. Pharmacology (1974) 1.70
Acetaminophen-induced hepatic necrosis. V. Correlation of hepatic necrosis, covalent binding and glutathione depletion in hamsters. Pharmacology (1974) 1.43
Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology (1995) 1.36
Primaquine-induced hemolytic anemia: formation and hemotoxicity of the arylhydroxylamine metabolite 6-methoxy-8-hydroxylaminoquinoline. J Pharmacol Exp Ther (2001) 1.19
Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy. Chest (1975) 1.12
Role of dapsone hydroxylamine in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther (1988) 1.06
Role of aniline metabolites in aniline-induced hemolytic anemia. J Pharmacol Exp Ther (1986) 1.04
Species differences in hepatic glutathione depletion, covalent binding and hepatic necrosis after acetaminophen. Life Sci (1974) 1.02
Contribution of aniline metabolites to aniline-induced methemoglobinemia. Mol Pharmacol (1987) 1.02
Role of detoxifying enzymes in bromobenzene-induced liver necrosis. J Pharmacol Exp Ther (1973) 0.99
Role of sterols in Saccharomyces cerevisiae. Biochim Biophys Acta (1968) 0.98
The role of cytochrome P-450 in N-hydroxylation of 2-acetylaminofluorene. Mol Pharmacol (1973) 0.94
Acetaminophen structure-toxicity studies: in vivo covalent binding of a nonhepatotoxic analog, 3-hydroxyacetanilide. Toxicol Appl Pharmacol (1990) 0.92
Role of metabolites in propanil-induced hemolytic anemia. Toxicol Appl Pharmacol (1991) 0.91
Mechanisms of fasting-induced potentiation of acetaminophen hepatotoxicity in the rat. Biochem Pharmacol (1987) 0.91
Glutathione thresholds in reactive metabolite toxicity. Arch Toxicol Suppl (1980) 0.90
Contribution of 3,4-dichlorophenylhydroxylamine in propanil-induced hemolytic anemia. Adv Exp Med Biol (1991) 0.89
Hepatic necrosis caused by furosemide. Nature (1974) 0.89
Metabolic activation of furosemide to a chemically reactive, hepatotoxic metabolite. J Pharmacol Exp Ther (1976) 0.88
Increased resistance of diabetic rats to acetaminophen-induced hepatotoxicity. J Pharmacol Exp Ther (1982) 0.86
Drug metabolism as a cause of drug toxicity. Drug Metab Dispos (1974) 0.85
Correlation between extent of liver damage in fulminant hepatic necrosis and complexing of circulating group-specific component (vitamin D-binding protein). J Lab Clin Med (1987) 0.85
Effects of sulfur-amino acid-deficient diets on acetaminophen metabolism and hepatotoxicity in rats. Toxicol Appl Pharmacol (1989) 0.83
Formation of chemically reactive metabolites of phenacetin and acetaminophen. Adv Exp Med Biol (1981) 0.82
Role of lipid peroxidation in dapsone-induced hemolytic anemia. J Pharmacol Exp Ther (1998) 0.81
Biochemical changes after hepatic injury from toxic doses of acetaminophen or furosemide. Pharmacology (1976) 0.80
Favism: effect of divicine on rat erythrocyte sulfhydryl status, hexose monophosphate shunt activity, morphology, and membrane skeletal proteins. Toxicol Sci (2001) 0.80
Favism: divicine hemotoxicity in the rat. Toxicol Sci (1999) 0.80
Acetaminophen hepatotoxicity: studies on the mechanism of cysteamine protection. Toxicol Appl Pharmacol (1986) 0.79
Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv Exp Med Biol (1986) 0.79
Formation of free radicals and protein mixed disulfides in rat red cells exposed to dapsone hydroxylamine. Free Radic Biol Med (1997) 0.79
Galactosamine hepatotoxicity: effect of galactosamine on glutathione resynthesis in rat primary hepatocyte cultures. Toxicol Appl Pharmacol (1992) 0.79
Chemical analysis and hemolytic activity of the fava bean aglycon divicine. Chem Res Toxicol (1993) 0.78
Cellular glutathione as a protective agent against 4-hydroperoxycyclophosphamide cytotoxicity in K-562 cells. Cancer Chemother Pharmacol (1990) 0.78
Strain differences in susceptibility of normal and diabetic rats to acetaminophen hepatotoxicity. Biochem Pharmacol (1986) 0.77
Role of glutathione in the in vitro synergism between 4-hydroperoxy-cyclophosphamide and cisplatin in leukemia cell lines. Cancer Res (1991) 0.77
The role of N-hydroxyphenetidine in phenacetin-induced hemolytic anemia. Toxicol Appl Pharmacol (1991) 0.77
Identification of free radicals produced in rat erythrocytes exposed to hemolytic concentrations of phenylhydroxylamine. Free Radic Biol Med (1995) 0.77
N-hydroxylation of p-chloroacetanilde in hamsters. Biochem Pharmacol (1976) 0.77
Vasopressin stimulates thromboxane synthesis in isolated hamster hepatocytes: relation to hepatocyte calcium content. Prostaglandins (1983) 0.76
Dapsone-induced hemolytic anemia: effect of dapsone hydroxylamine on sulfhydryl status, membrane skeletal proteins and morphology of human and rat erythrocytes. J Pharmacol Exp Ther (1995) 0.76
Effect of cobalt protoporphyrin on hepatic drug-metabolizing enzymes. Specificity for cytochrome P-450. Biochem Pharmacol (1989) 0.76
Dapsone-induced hemolytic anemia: effect of N-hydroxy dapsone on the sulfhydryl status and membrane proteins of rat erythrocytes. Toxicol Appl Pharmacol (1992) 0.76
Role of UDPGA flux in acetaminophen clearance and hepatotoxicity. Xenobiotica (1984) 0.75
Improved method for determination of cellular thiols, disulfides and protein mixed disulfides using HPLC with electrochemical detection. Adv Exp Med Biol (1986) 0.75
Mechanism of ketone-induced protection from acetaminophen hepatotoxicity in the rat. Drug Metab Dispos (1983) 0.75
Effect of glucose and gluconeogenic substrates on fasting-induced suppression of acetaminophen glucuronidation in the rat. Biochem Pharmacol (1989) 0.75
Relationship between sulfotransferase activity and susceptibility to acetaminophen-induced liver necrosis in the hamster. Drug Metab Dispos (1987) 0.75
Anomalous susceptibility of the fasted hamster to acetaminophen hepatotoxicity. Biochem Pharmacol (1986) 0.75
Tolerance to nitroglycerin in vascular smooth muscle cells is not affected by the level of intracellular glutathione or L-cysteine. Anesth Analg (1995) 0.75
Rapid and sensitive method for the microassay of nitrosobenzene plus phenylhydroxylamine in blood. J Chromatogr (1983) 0.75
Proceedings: Mechanisms of drug absorption and of drug solution. Rev Can Biol (1973) 0.75
Diminished serum Gc (vitamin D-binding protein) levels and increased Gc:G-actin complexes in a hamster model of fulminant hepatic necrosis. Hepatology (1987) 0.75
Hydroxylamines and hemolytic anemia. Adv Exp Med Biol (1986) 0.75
Biochemical basis for dose response relationships in reactive metabolite toxicity. Adv Exp Med Biol (1981) 0.75
Effect of L-ascorbic acid on acetaminophen-induced hepatotoxicity and covalent binding in hamsters. Evidence that in vitro covalent binding differs from that in vivo. Drug Metab Dispos (1984) 0.75
Arylamine-induced hemolytic anemia: electron spin resonance spectrometry studies. Adv Exp Med Biol (1991) 0.75
Macrophage enhancement of galactosamine hepatotoxicity using a rat hepatocyte culture system. Res Commun Mol Pathol Pharmacol (1995) 0.75
Lack of in vivo evidence of a cytochrome P450 metabolite participating in aminoglycoside nephrotoxicity. Biochem Pharmacol (1993) 0.75
Pharmacokinetic considerations in toxicity testing. Drug Metab Rev (1982) 0.75
Acetaminophen overdosage. J S C Med Assoc (1977) 0.75
Use of the NIH shift to determine the relative contribution of competing pathways of aniline metabolism in the rat. Drug Metab Dispos (1987) 0.75
Mechanisms of drug absorption and of drug solution. Pharmacology (1972) 0.75
The mechanisms of cobalt chloride-induced protection against acetaminophen hepatotoxicity. Drug Metab Dispos (1986) 0.75